POMT1
Protein O-mannosyl-transferase 1
Also known as: LGMD2K, POMT1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y6A1
- Gene
- POMT1
- Ensembl
- ENSG00000130714
- Chromosome
- 9
- Canonical length
- 747 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Golgi apparatus
OverviewNCBI Gene
The protein encoded by this gene is an O-mannosyltransferase that requires interaction with the product of the POMT2 gene for enzymatic function. The encoded protein is found in the membrane of the endoplasmic reticulum. Defects in this gene are a cause of Walker-Warburg syndrome (WWS) and limb-girdle muscular dystrophy type 2K (LGMD2K). Several transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Oct 2008]
Canonical amino-acid sequenceUniProt
747 residues, UniProt reviewed canonical sequence.
>Q9Y6A1|POMT1
1 MWGFLKRPVV VTADINLSLV ALTGMGLLSR LWRLTYPRAV VFDEVYYGQY ISFYMKQIFF
61 LDDSGPPFGH MVLALGGYLG GFDGNFLWNR IGAEYSSNVP VWSLRLLPAL AGALSVPMAY
121 QIVLELHFSH CAAMGAALLM LIENALITQS RLMLLESVLI FFNLLAVLSY LKFFNCQKHS
181 PFSLSWWFWL TLTGVACSCA VGIKYMGVFT YVLVLGVAAV HAWHLLGDQT LSNVGADVQC
241 CMRPACMGQM QMSQGVCVFC HLLARAVALL VIPVVLYLLF FYVHLILVFR SGPHDQIMSS
301 AFQASLEGGL ARITQGQPLE VAFGSQVTLR NVFGKPVPCW LHSHQDTYPM IYENGRGSSH
361 QQQVTCYPFK DVNNWWIVKD PRRHQLVVSS PPRPVRHGDM VQLVHGMTTR SLNTHDVAAP
421 LSPHSQEVSC YIDYNISMPA QNLWRLEIVN RGSDTDVWKT ILSEVRFVHV NTSAVLKLSG
481 AHLPDWGYRQ LEIVGEKLSR GYHGSTVWNV EEHRYGASQE QRERERELHS PAQVDVSRNL
541 SFMARFSELQ WRMLALRSDD SEHKYSSSPL EWVTLDTNIA YWLHPRTSAQ IHLLGNIVIW
601 VSGSLALAIY ALLSLWYLLR RRRNVHDLPQ DAWLRWVLAG ALCAGGWAVN YLPFFLMEKT
661 LFLYHYLPAL TFQILLLPVV LQHISDHLCR SQLQRSIFSA LVVAWYSSAC HVSNTLRPLT
721 YGDKSLSPHE LKALRWKDSW DILIRKHLocalizationUniProt · AlphaFold · HPA
Whether an antibody against POMT1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 12
- Mean surface accessibility (rSASA)
- 0.25
- Highest tissue expression
- 20 nTPM
Expression across tissuesHPA
Tissue
- hippocampal formation: 20 nTPM
- testis: 18 nTPM
- cerebellum: 16 nTPM
- skeletal muscle: 15 nTPM
- choroid plexus: 15 nTPM
- cerebral cortex: 14 nTPM
Single-cell type
- early spermatids: 85 nCPM
- late primary spermatocytes: 77 nCPM
- myonuclei: 73 nCPM
- early primary spermatocytes: 57 nCPM
- retinal ganglion cells: 54 nCPM
- late spermatids: 53 nCPM
Immune cell
- MAIT T-cell: 7.1 nTPM
- T-reg: 5 nTPM
- gdT-cell: 4.7 nTPM
- memory CD8 T-cell: 4.7 nTPM
- memory CD4 T-cell: 4.5 nTPM
- naive CD4 T-cell: 4.4 nTPM
Brain region
- hippocampal formation: 17 nTPM
- cerebral cortex: 11 nTPM
- medulla oblongata: 8.9 nTPM
- thalamus: 8.5 nTPM
- pons: 8.3 nTPM
- cerebellum: 7.8 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about POMT1.
Disease | AllUniProt
Conditions POMT1 is implicated in, by any mechanism.
- Muscular dystrophy-dystroglycanopathy congenital with impaired intellectual development B1 (MDDGB1) MIM:613155
- Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A1 (MDDGA1) MIM:236670
- Muscular dystrophy-dystroglycanopathy limb-girdle C1 (MDDGC1) MIM:609308
Disease | GeneticClinVar
199 pathogenic / likely-pathogenic of 1,302 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1
- Autosomal recessive limb-girdle muscular dystrophy type 2K
- Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1
- Walker-Warburg congenital muscular dystrophy
- Autosomal recessive limb-girdle muscular dystrophy
Disease | ImmuneIEDB
Conditions an epitope on POMT1 was assayed in.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.93
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.62
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- extracellular matrix organization
- protein O-linked glycosylation
- protein O-linked glycosylation via mannose
Molecular functions
- dolichyl-phosphate-mannose-protein mannosyltransferase activity
- mannosyltransferase activity
- metal ion binding
Cellular components
- acrosomal vesicle
- endoplasmic reticulum
- endoplasmic reticulum membrane
- membrane
- sarcoplasmic reticulum
- dolichyl-phosphate-mannose-protein mannosyltransferase complex
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of POMT1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads POMT1 as an antibody target. Whether an autoantibody or antibody against POMT1 could matter depends on whether native POMT1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
POMT1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label POMT1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...